Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Common Stock Redeemable Convertible Preferred Stock	Common Stock Series B and Series C Redeemable Convertible Preferred Stock	Common Stock Series C Redeemable Convertible Preferred Stock	Common Stock Common stock warrants	Common Stock	Additional Paid-in Capital Redeemable Convertible Preferred Stock	Additional Paid-in Capital Series B and Series C Redeemable Convertible Preferred Stock	Additional Paid-in Capital Series C Redeemable Convertible Preferred Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Redeemable Convertible Preferred Stock	Series B and Series C Redeemable Convertible Preferred Stock	Series C Redeemable Convertible Preferred Stock	Total
Beginning Balance at Dec. 31, 2019					$ 3				$ 203,492	$ (263,474)					$ (59,979)
Beginning Balance (in shares) at Dec. 31, 2019					34,197,822
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive loss										(54,032)					(54,032)
Stock-based compensation									10,660						10,660
Stock-based compensation - earnout									636						636
Stock-based compensation - earnout (in shares)					1,976,332
Issuance of common stock for acquisitions									6,898						6,898
Issuance of common stock for acquisitions (in shares)					785,330
Exercise of stock options									1,029						1,029
Exercise of stock options (in shares)					505,711
Net share settlement of common stock options and restricted stock units					1,189,911
Inducement to convert preferred stock									(17,284)						(17,284)
Impacts of recognition of contingent beneficial conversion feature									(5,208)						(5,208)
Recapitalization and PIPE financing					$ 5				239,722						239,727
Recapitalization and PIPE financing (in shares)					35,304,052
Tax impacts of recapitalization									187						187
Earnout liability									(50,238)						(50,238)
Earnout liability (in shares)					4,023,668
Cancellation of redeemable convertible preferred stock repurchase liability									480						480
Issuance of Series C redeemable convertible preferred stock							$ 4,836						$ 4,836
Issuance of Series C redeemable convertible preferred stock (in shares)		682,539
Conversion of convertible notes to Series C redeemable convertible preferred stock						$ 11,029		$ 1,436				$ 11,029		$ 1,436
Conversion of convertible notes to Series C redeemable convertible preferred stock (in shares)	702,791		198,750	1,705,266
Vesting of restricted stock awards issued for acquisitions (in shares)					472,141
Shareholder contribution									17,584						17,584
Issuance of common stock warrants									44						44
Shares repurchased						$ 480						$ 480
Shares repurchased (in shares)	(75,162)
Ending Balance at Dec. 31, 2020					$ 8				424,823	(317,506)					107,325
Ending Balance (in shares) at Dec. 31, 2020					81,669,151
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive loss										(106,606)	$ (259)				(106,865)
Stock-based compensation									15,631						15,631
Stock-based compensation - earnout									22,961						22,961
Issuance of common stock for acquisitions					$ 1				35,706						35,707
Issuance of common stock for acquisitions (in shares)					2,042,652
Contingent consideration for acquisitions									6,685						6,685
Reclassification of earnout liability upon vesting									54,891						54,891
Reclassification of private warrant liability upon exercise									31,730						31,730
Vesting of restricted stock awards (in shares)					2,549,223
Exercise of stock warrants					$ 1				126,768						126,769
Exercise of stock warrants (in shares)					11,521,412
Exercise of stock options									4,326						4,326
Exercise of stock options (in shares)					1,700,557
Income tax withholdings									(28,940)						(28,940)
Income tax withholdings (in shares)					(1,521,398)
Transaction costs									(262)						(262)
Capped call transactions									(52,913)						(52,913)
Ending Balance at Dec. 31, 2021					$ 10				641,406	(424,112)	(259)				217,045
Ending Balance (in shares) at Dec. 31, 2021					97,961,597
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive loss															(11,800)
Ending Balance at Mar. 31, 2022															211,392
Beginning Balance at Dec. 31, 2021					$ 10				641,406	(424,112)	(259)				217,045
Beginning Balance (in shares) at Dec. 31, 2021					97,961,597
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive loss															(40,910)
Ending Balance at Jun. 30, 2022															194,543
Beginning Balance at Dec. 31, 2021					$ 10				641,406	(424,112)	(259)				217,045
Beginning Balance (in shares) at Dec. 31, 2021					97,961,597
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive loss															(127,398)
Ending Balance at Sep. 30, 2022															112,603
Beginning Balance at Dec. 31, 2021					$ 10				641,406	(424,112)	(259)				217,045
Beginning Balance (in shares) at Dec. 31, 2021					97,961,597
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive loss										(156,559)	(5,912)				(162,471)
Stock-based compensation									27,041						27,041
Issuance of common stock for acquisitions									3,552						3,552
Issuance of common stock for acquisitions (in shares)					628,660
Contingent consideration for acquisitions									530						530
Vesting of restricted stock awards (in shares)					2,144,546
Exercise of stock options									1,116						$ 1,116
Exercise of stock options (in shares)					473,653										473,653
Income tax withholdings									(3,108)						$ (3,108)
Income tax withholdings (in shares)					(613,377)
Shares repurchased										4,352					4,352
Shares repurchased (in shares)					(2,388,756)
Ending Balance at Dec. 31, 2022					$ 10				670,537	(585,023)	(6,171)				79,353
Ending Balance (in shares) at Dec. 31, 2022					98,206,323
Beginning Balance at Mar. 31, 2022															211,392
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive loss															(29,110)
Ending Balance at Jun. 30, 2022															194,543
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive loss															(86,488)
Ending Balance at Sep. 30, 2022															112,603
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive loss															$ (35,073)
Shares repurchased (in shares)															2,388,756
Ending Balance at Dec. 31, 2022					$ 10				$ 670,537	$ (585,023)	$ (6,171)				$ 79,353
Ending Balance (in shares) at Dec. 31, 2022					98,206,323